2-甲基烯丙基胺 盐酸盐 | 28148-54-1

• 物质功能分类: 有机原料 - 烃类化合物及其衍生物 - 无环烃
• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 2-甲基烯丙基胺 盐酸盐
• 中文别名: 2-甲基烯丙基胺盐酸盐；2-甲基丙烯胺盐酸盐
• 英文名称: 2-methylallylamine hydrochloride
• 英文别名: 2-methyl-2-propen-1-amine monohydrochloride；2-methyl-2-propenylamine hydrochloride；methallylamine hydrochloride；2-Methylprop-2-enylazanium;chloride；2-methylprop-2-enylazanium;chloride
• CAS: 28148-54-1
• 化学式: C₄H₉N*ClH
• mdl: MFCD00012876
• 分子量: 107.583
• InChiKey: IOXCSDPJYGPYFW-UHFFFAOYSA-N

物化性质

• 熔点：
  179-184 °C(lit.)
• 稳定性/保质期：
  遵照规定使用和储存，则不会分解。

计算性质

• 辛醇/水分配系数(LogP)：
  0.35
• 重原子数：
  6
• 可旋转键数：
  1
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  26
• 氢给体数：
  2
• 氢受体数：
  1

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S37/39
• 危险类别码：
  R36/37/38
• WGK Germany：
  3
• 海关编码：
  2921199090

SDS

---

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : 2-Methylallylamine hydrochloride
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
CAS-No. : 28148-54-1
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Skin irritation (Category 2), H315
Eye irritation (Category 2), H319
Specific target organ toxicity - single exposure (Category 3), H335
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Xi Irritant R36/37/38
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal word Warning
Hazard statement(s)
H315 Causes skin irritation.
H319 Causes serious eye irritation.
H335 May cause respiratory irritation.
Precautionary statement(s)
P261 Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
Supplemental Hazard none
Statements
Other hazards - none

---

SECTION 3: Composition/information on ingredients
Substances
Chemical characterization : Natural product
Formula : C4H9N · HCl
Molecular Weight : 107,58 g/mol
CAS-No. : 28148-54-1
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
2-Methylallylamine hydrochloride
CAS-No. 28148-54-1 Skin Irrit. 2; Eye Irrit. 2; STOT <= 100 %
SE 3; H315, H319, H335
Hazardous ingredients according to Directive 1999/45/EC
Component Classification Concentration
2-Methylallylamine hydrochloride
CAS-No. 28148-54-1 Xi, R36/37/38 <= 100 %
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

---

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
no data available

---

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx)
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure
adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
For personal protection see section 8.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

---

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.Normal measures for preventive fire
protection.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
hygroscopic
Specific end use(s)
A part from the uses mentioned in section 1.2 no other specific uses are stipulated

---

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested
and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Full contact
Material: Nitrile rubber
Minimum layer thickness: 0,11 mm
Break through time: 480 min
Material tested:Dermatril® (KCL 740 / Z677272, Size M)
Splash contact
Material: Nitrile rubber
Minimum layer thickness: 0,11 mm
Break through time: 480 min
Material tested:Dermatril® (KCL 740 / Z677272, Size M)
data source: KCL GmbH, D-36124 Eichenzell, phone [phone], test method: EN374
If used in solution, or mixed with other substances, and under conditions which differ from EN 374,
contact the supplier of the CE approved gloves. This recommendation is advisory only and must
be evaluated by an industrial hygienist and safety officer familiar with the specific situation of
anticipated use by our customers. It should not be construed as offering an approval for any
specific use scenario.
Body Protection
impervious clothing, The type of protective equipment must be selected according to the
concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges.
Use respirators and components tested and approved under appropriate government standards
such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Do not let product enter drains.

---

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing Melting point/range: 179 - 184 °C - lit.
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evapouration rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- no data available
octanol/water
p) Auto-ignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

SECTION 10: Stability and reactivity
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available
In the event of fire: see section 5

---

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitisation
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
Inhalation - May cause respiratory irritation.
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

---

SECTION 12: Ecological information
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
no data available

---

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed
professional waste disposal service to dispose of this material. Dissolve or mix the material with a
combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

---

SECTION 14: Transport information
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

---

---

SECTION 15 - REGULATORY INFORMATION
N/A

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-甲基烯丙基胺 盐酸盐 在 magnesium sulfate 、 苯甲醛 、 三乙胺 、 溴 、 氢溴酸 作用下， 以 二氯甲烷 、 水 为溶剂， 反应 6.25h， 以62%的产率得到2,3-dibromo-2-methylpropylamine hydrobromide
  参考文献：
  名称：

  经由氮丙啶至氮丙啶重排的3-甲氧氮杂环丁烷的合成及反应机理的理论合理化

  摘要：

  N-亚烷基-（2,3-二溴-2-甲基丙叉基）胺和N-（2,3-二溴-2-甲基丙叉基）苄胺的合成效用是通过3-甲氧基-3-甲基氮杂环丁烷的意外合成证明的在稀有氮丙啶至氮杂环丁烷重排的回流条件下，用硼氢化钠的甲醇溶液处理。这些发现与密切相关的N-亚烷基-（2，3-二溴丙基）胺的已知反应性相反，所述N-亚烷基-（2，3-二溴丙基）胺在相同反应条件下容易转化为2-（溴甲基）氮丙啶。实验研究和理论合理性均提供了对反应机理的深入了解。

  DOI：

  10.1021/jo102555r
• 作为产物：
  描述：

  (1,3-dimethyl-2-oxo-2λ⁵-[1,3,2]diazaphospholidin-2-yl)-(2-methyl-allyl)-phosphoramidic acid diphenyl ester 在 盐酸 作用下， 以 甲醇 为溶剂， 以87%的产率得到2-甲基烯丙基胺 盐酸盐
  参考文献：
  名称：

  钯催化的（烯丙氧基）亚氨基二氮杂膦的烯丙基转座：用于立体选择性合成烯丙胺的正式 [3,3]-Aza-phospha-oxa-Cope Sigmatropic 重排

  摘要：

  N-保护的烯丙胺的合成是利用钯 (II) 催化的（烯丙氧基）亚氨基二氮杂膦的 [3,3]-重排实现的。这种 [3,3]-氮杂-磷杂-氧杂-Cope sigmatropic 重排反应在热力学上由 P=N 到 P=O 的互变驱动，是 Overman 重排的替代方法。整个过程包括将烯丙醇亲核置换到 P(III) 前体上，然后进行施陶丁格反应以生成（烯丙氧基）亚氨基二氮杂磷脂前体。Pd(II)-催化的[3,3]-氮杂-磷-氧杂-Cope重排然后产生磷酰胺，其在酸性条件下容易水解以产生烯丙胺衍生物。据信，Pd(II) 催化以类似于烯丙基亚氨酸酯重排的方式发生。外消旋的范围，描述了这种重排的非对映选择性和对映选择性变体。报道了手性二胺助剂在非对映选择性重排中的使用。手性 N,N'-二甲基环己二胺衍生的二氮杂磷脂的重排产生具有中等非对映选择性（高达 3.5:1 dr）的磷酰胺。无论起始烯丙醇几何结构如何

  DOI：

  10.1021/ja054161k

文献信息

• Synthesis of Oxazolidinones by a Hypervalent Iodine Mediated Cyclization of <i>N</i> ‐Allylcarbamates
  作者：Mirdyul Das、Arantxa Rodríguez、Pui Kin Tony Lo、Wesley J. Moran

  DOI：10.1002/adsc.202001451

  日期：2021.3.16

  The preparation of oxazolidinones by the hypervalent iodine mediated cyclization of allylcarbamates is described. A versatile range of substrates can be converted into substituted oxazolidinones primed for further transformations. Derivatization of the products at both ends is demonstrated. A preliminary attempt at the enantioselective formation of an oxazolidinone using a chiral iodane is also presented

  描述了通过高价碘介导的烯丙基氨基甲酸酯的环化制备恶唑烷酮。可以将多种底物转化为准备用于进一步转化的取代的恶唑烷酮。说明了两端产品的衍生化。还提出了使用手性碘对映体形成恶唑烷酮的初步尝试。
• Sulfonamide inhibitors of aspartyl protease
  申请人：Vertex Pharmaceuticals, Incorporated

  公开号：US06372778B1

  公开（公告）日：2002-04-16

  The present invention relates to a novel class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of HIV aspartyl protease inhibitors characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HIV-1 and HIV-2 protease activity and consequently, may be advantageously used as anti-viral agents against the HIV-1 and HIV-2 viruses. This invention also relates to methods for inhibiting the activity of HIV aspartyl protease using the compounds of this invention and methods for screening compounds for anti-HIV activity.

  本发明涉及一种新型磺胺类化合物，其为天冬氨酸蛋白酶抑制剂。在一个实施例中，本发明涉及一种新型HIV天冬氨酸蛋白酶抑制剂，其具有特定的结构和理化特征。本发明还涉及包含这些化合物的药物组合物。本发明的化合物和药物组合物特别适用于抑制HIV-1和HIV-2蛋白酶活性，因此，可以有利地用作抗HIV-1和HIV-2病毒的抗病毒剂。本发明还涉及使用本发明的化合物抑制HIV天冬氨酸蛋白酶活性的方法，以及筛选具有抗HIV活性的化合物的方法。
• Antiparasitic Activity of Sulfur- and Fluorine-Containing Bisphosphonates against Trypanosomatids and Apicomplexan Parasites
  作者：Tamila Galaka、Mariana Ferrer Casal、Melissa Storey、Catherine Li、María Chao、Sergio Szajnman、Roberto Docampo、Silvia Moreno、Juan Rodriguez

  DOI：10.3390/molecules22010082

  日期：——

  Based on crystallographic data of the complexes 2-alkyl(amino)ethyl-1,1-bisphosphonates–Trypanosoma cruzi farnesyl diphosphate synthase, some linear 1,1-bisphosphonic acids and other closely related derivatives were designed, synthesized and biologically evaluated against T. cruzi, the responsible agent of Chagas disease and against Toxoplasma gondii, the etiologic agent of toxoplasmosis and also towards the target enzymes farnesyl pyrophosphate synthase of T. cruzi (TcFPPS) and T gondii (TgFPPS), respectively. The isoprenoid-containing 1,1-bisphosphonates exhibited modest antiparasitic activity, whereas the linear α-fluoro-2-alkyl(amino)ethyl-1,1-bisphosphonates were unexpectedly devoid of antiparasitic activity. In spite of not presenting efficient antiparasitic activity, these data turned out to be very important to establish a structural activity relationship.

  基于2-烷基（氨基）乙基-1,1-双膦酸酯与克鲁兹锥虫法尼基二磷酸合成酶的晶体学数据，设计、合成了一些线性1,1-双膦酸及其他密切相关的衍生物，并对其在针对克鲁兹锥虫（造成查加斯病的病原体）和弓形虫（造成弓形虫病的病原体）的生物活性进行了评估，同时也针对克鲁兹锥虫（TcFPPS）和弓形虫（TgFPPS）的目标酶法尼基焦磷酸合成酶进行评估。含异戊烯基的1,1-双膦酸酯表现出适度的抗寄生虫活性，而线性α-氟-2-烷基（氨基）乙基-1,1-双膦酸酯则出人意料地缺乏抗寄生虫活性。尽管未表现出有效的抗寄生虫活性，这些数据对于建立结构活性关系却显得非常重要。
• P-subsituted propane-phosphinic acid compounds
  申请人：Ciba-Geigy Corporation

  公开号：US05190934A1

  公开（公告）日：1993-03-02

  Compounds of the formula I ##STR1## wherein either R.sub.1 is halogen, R.sub.1 ' is halogen or hydrogen and R.sub.2 and R.sub.2 ' denote hydrogen or R.sub.1 and R.sub.1 ' represent hydrogen, R.sub.2 is an aliphatic or aromatic radical and R.sub.2 ' is hydroxy or R.sub.2 and R.sub.2 ' together represent oxo, and wherein R denotes an aliphatic, cycloaliphatic, cycloaliphatic-aliphatic or araliphatic radical having 2 or more carbon atoms or, if R.sub.1 and R.sub.1 ' denote hydrogen, R.sub.2 represents an aromatic radical and R.sub.2 ' is hydroxy, R represents methyl, and their salts are useful as nootropics, antidepressants and/or anxiolytics. The can be manufacture by replacing any group R.sub.5 by hydrogen and/or converting any group Z.sub.0 into amino in a compound of formula II ##STR2## in which R, R.sub.1, R.sub.1 ', R.sub.2 and R.sub.2 ' have their previous significances, Z represents a protected or latent amino group Z.sub.0 and R.sub.4 denotes hydrogen or a hyddroxy-protective group R.sub.5, and wherein amino as a constituent of R and/or hydroxy R.sub.2 ' or oxo R.sub.2 +R.sub.2 ' may be present in a temporarily protected form.

  式I的化合物##STR1##中，R.sub.1为卤素，R.sub.1'为卤素或氢，R.sub.2和R.sub.2'表示氢或R.sub.1和R.sub.1'代表氢，R.sub.2为脂肪族或芳香基团，R.sub.2'为羟基或R.sub.2和R.sub.2'一起表示羰基，其中R表示具有2个或更多碳原子的脂肪族、环脂肪族、环脂肪族-脂肪族或芳基脂肪族基团，或者如果R.sub.1和R.sub.1'表示氢，则R.sub.2表示芳香基团，R.sub.2'为羟基，R表示甲基，它们的盐可用作脑功能增强剂、抗抑郁剂和/或抗焦虑剂。可以通过将任何基团R.sub.5替换为氢和/或将任何基团Z.sub.0转化为氨基来制备，其中R、R.sub.1、R.sub.1'、R.sub.2和R.sub.2'具有其先前的含义，Z表示受保护或潜在的氨基团Z.sub.0，R.sub.4表示氢或羟基保护基团R.sub.5，氨基作为R的组分和/或羟基R.sub.2'或羰基R.sub.2+R.sub.2'可能以暂时受保护的形式存在于式II的化合物中##STR2##。
• Diverse Reactivity in a Rhodium(III)-Catalyzed Oxidative Coupling of<i>N</i>-Allyl Arenesulfonamides with Alkynes
  作者：Dongqi Wang、Fen Wang、Guoyong Song、Xingwei Li

  DOI：10.1002/anie.201206918

  日期：2012.12.3

  Olefinic CH activation of N‐allyl sulfonamides in the presence of [RhCp*Cl2}2] (Cp*=Me5C5) enabled their oxidative coupling with alkynes to generate 1,2‐dihydropyridines, pyridines, and cyclopentenones (see scheme; Ts=p‐toluenesulfonyl). The type of highly substituted product formed was controlled by the substitution of the allyl group and the reaction conditions.

  烯Ç  ħ活化的ñ -烯丙基中的存在磺酰胺[RHCP *氯2 } 2 ]（CP * =我5 Ç 5）启用与炔其氧化偶合，以生成1,2-二氢吡啶，吡啶，和环戊烯酮（参见方案； Ts =对甲苯磺酰基）。形成的高度取代的产物的类型通过烯丙基的取代和反应条件来控制。